Language selection

Government of Canada / Gouvernement du Canada

Search

Immunomodulator for asthma treatment (L-11894) .: NR16-175/2017E-PDF

“To address the need for a safe, disease-modifying treatment, the NRC has developed an immunomodulator that suppresses the unbalanced immune response that causes asthma”--Highlights.

Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.847586&sl=0

Publication information
Department/Agency
  • National Research Council Canada.
TitleImmunomodulator for asthma treatment (L-11894) .
Publication typeMonograph
Language[English]
Other language editions[French]
FormatDigital text
Electronic document
Note(s)
  • Issued also in French under title: Immunomodulateur pour le traitement de l’asthme (L-11894).
  • Caption title.
  • "December 2017."
  • Issued also in print format.
Publishing information
  • [Ottawa] : National Research Council Canada, [2018]
Description[1] p. : col. ill.
ISBN9780660239637
Catalogue number
  • NR16-175/2017E-PDF
Subject terms
Request alternate formats
To request an alternate format of a publication, complete the Government of Canada Publications email form. Use the form’s “question or comment” field to specify the requested publication.

Page details

Report a problem or mistake on this page
Date modified: